ClinicalTrials.gg
CompletedNCT05275543Updated Oct 28, 2026Results posted

Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab

An interventional study of Paro Robot in Pediatric ALL, Child, Hospitalized and Physical Therapy Modalities, sponsored by University of Nebraska. Completed at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by University of Nebraska · Not applicable, Interventional, and Treatment

How we know

Updated Oct 28, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska — none open to participants now, none under way, none of them phase 3. Precursor Cell Lymphoblastic Leukemia-Lymphoma · University of Nebraska.

Started
2022
the only one that year
No phase
2 of 12
none open now
Registered
12th of 12
by date

Among the 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska, this one is the only one that started in 2022, is one of 2 with no phase, and was the 12th registered.

Precursor Cell Lymphoblastic Leukemia-Lymphoma

2,586 studies on the registry are indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma; 471 are open to participants now.

Browse Precursor Cell Lymphoblastic Leukemia-Lymphoma studies →

Open to participants now

None of the 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska is open now. The open studies under Precursor Cell Lymphoblastic Leukemia-Lymphoma, anywhere →

Where they have run

Who these studies take

Of the 369 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies recruiting now, 96 (26%) set no upper age limit and 257 (70%) stop at 75 or younger; 247 take children under 18; 29 take healthy volunteers.

This study: 5 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska as a file.
02

Study summary

The purpose of this study is to:

Aim 1: Evaluate the feasibility [consent and refusal rates, attrition rates, length, and number of completed therapy sessions], and acceptability [interviews with children and guardians, overall patient and guardian satisfaction] during inpatient physical therapy (PT) and occupational therapy (OT) sessions. Hypothesis: Animal-assisted interaction (AAI) with Paro, a robotic baby harp seal, during pediatric inpatient PT/OT sessions will be feasible and acceptable.

Aim 2: Assess preliminary efficacy of AAI during PT/OT sessions with Paro on behavior (anxiety and affect) and motivation to participate in rehabilitation in hospitalized children. Hypothesis: Children who use Paro will demonstrate less anxiety, more positive affect, and greater motivation to participate in therapy than those who do not use Paro.

Aim 3: Test the stress, anxiety, and depression levels of parents/guardians of children who use Paro inpatient physical and occupational therapy sessions. Hypothesis: In addition, parents and guardians of children that use Paro will report less stress, anxiety, and depression compared to parents/guardians of children that do not use Paro.

Read the detailed description

Animal Assisted Interactions (AAIs) are interventions that intentionally incorporate animals as part of a therapeutic process to promote human health, learning, and well-being. In general, domestic and farm animals such as dogs, cats, birds, equines, guinea pigs, rabbits, llamas, sheep, goats, and pigs are predominantly featured in AAI programs. Animals can be observed, held, and petted, or more actively integrated into specific therapy activities such as brushing with different tools to encourage range of motion and fine motor coordination. AAIs also promote exercise through tandem walking with the animals. Recent literature indicates that AAI can improve reality orientation and attention span, eliminate the sense of isolation, reduce stress and anxiety, enhance communication, promote positive social interactions, and enhance overall quality of life. The use of AAI in hospitalized children has the potential to engage patients, family members, and healthcare staff in an innovative, holistic approach to recovery.

While additional research is warranted to further explore the potential impact of AAI on a variety of clinically meaningful patient outcomes, the highly technical, fast-paced hospital environment and the immunocompromised health statuses of many acutely ill hospitalized patients greatly limit the exploration of AAI in inpatient settings. A new frontier in animal robotics opens a vast array of opportunities to implement AAI in hospitalized populations. Robot animals may be just as effective as live animals and may provide even more flexibility and tailoring to meet the needs of diverse situations that arise in the hospital. In addition, the infection control risk that live animals pose to hospitalized patients may be significantly lessened.

For this study, the investigators plan to conduct a two-armed randomized controlled trial with repeated measures. Hospitalized pediatric patients will participate in semi-structured, prescriptive physical and occupational therapy sessions on the categories of: 1) speech; 2) balance and endurance; 3) memory; 4) self-esteem; 5) fine motor; 6) sensory stimulation. Intervention group subjects (n=30) will participate in 10-30 minute therapy sessions with Paro, a therapeutic robotic baby harp seal. Control group subjects (n=30) will participate in 10-30 minute therapy sessions without Paro.

03

Conditions studied

  • Pediatric ALL
  • Child, Hospitalized
  • Physical Therapy Modalities
  • Occupational Therapy
  • Animal Assisted Therapy

Keywords

  • Robot
  • Animal Assisted Interaction
  • Hosptilization
  • Rehabiliation
  • Pediatric
04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 5-18
  • admitted to any of the five inpatient units at Children's Hospital and Medical Center, Omaha, NE
  • have an available parent or guardian
  • have an active consult request for PT or OT
  • awake, alert, able to follow commands
  • not delirious
  • able to understand English
  • free from significant vision or hearing deficits
  • able to verbalize.

Exclusion criteria

Exclusion Criteria:

  • Have a pacemaker
  • have airborne, enteric, or enhanced contact precautions
  • wounds without a covering dressing or a dressing that is visibly soiled
  • known adverse psychological reactions to animals
  • excessive secretions via nose or mouth
  • report feeling nauseated
  • shows signs of acute agitation (yelling, screaming, moaning, or is otherwise inconsolable).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Physical and Occupational Therapy with Paro Robot

    10-30 minute semi-structured, prescriptive therapy sessions with Paro robot focused on the categories of 1) speech; 2) balance and endurance; 3) memory; 4) self-esteem; 5) fine motor; 6) sensory stimulation

    Device: Paro Robot

  • No intervention
    Physical and Occupational Therapy without Paro Robot

    10-30 minute semi-structured, prescriptive therapy sessions without Paro robot focused on the categories of 1) speech; 2) balance and endurance; 3) memory; 4) self-esteem; 5) fine motor; 6) sensory stimulation

  • Experimental
    Parents/Guardians of Hospitalized Children who use Paro Robot

    Parents/guardians of hospitalized children who are assigned to the following arm "Physical and Occupational Therapy with Paro Robot"

    Device: Paro Robot

  • No intervention
    Parents/Guardians of Hospitalized Children who do not use Paro Robot

    Parents/guardians of hospitalized children who are assigned to the following arm "Physical and Occupational Therapy with out Paro Robot"

Interventions

  • DeviceParo Robot

    Device: PARO therapy seal PARO, a baby harp seal, is an advanced interactive, therapeutic medical robot developed by AIST, a leading Japanese industrial automation pioneer. It allows the documented benefits of animal therapy to be administered to patients in environments such as hospitals and extended care facilities where live animals present treatment or logistical difficulties.

06

What researchers measure

Primary outcomes

  1. Pain: Wrong-Baker FACES Pain Rating Scale

    The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  2. Anxiety: Children's Anxiety Meter-State (CAM-S)

    The Children's Anxiety Meter-State (CAM-S) scale is a visual drawing used to measure anxiety in children. It is drawn to resemble a thermometer with a bulb at the bottom and horizontal lines at intervals going up to the top. The child is instructed to indicate with a line how they are feeling. The bottom of the thermometer minimum number is 0, which represents not worried or not nervous with anxiety increasing as it goes to the top of the thermometer with a max number of 10, representing very worried or very nervous.

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  3. Intervention Acceptability

    Patient Satisfaction Measure: Investigator-developed Satisfaction Measure contains one item which asks the participants to rank their satisfaction with the intervention from 1-5 (1 being not at all satisfied and 5 being very much satisfied)

    Time frame: Assessed within 1 week following the participant's final (up to 4th) therapy session

  4. Number of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)

    A count of Central Line Associated Blood Stream Infections (CLABSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  5. Number of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)

    A count of Catheter-Associated Urinary Tract Infections (CAUTI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  6. Number of Hospital Acquired Infections-Enteroviruses

    A count of Enteroviruses infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  7. Number of Hospital Acquired Infections-Influenza

    A count of Influenza infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  8. Number of Hospital Acquired Infections-Multi-Drug Resistant Organisms

    A count of Multi-Drug Resistant Organism infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  9. Number of Hospital Acquired Infections-Surgical-Site Infections (SSI)

    A count of Surgical-Site Infections (SSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  10. Number of Hospital Acquired Infections Ventilator-Associated Pneumonia (VAP)

    A count of Ventilator-Associated Pneumonia (VAP) infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

    Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.

  11. Total Number of Participants With Sedation Exposure

    Sedative and analgesic medications will be abstracted from the electronic medical record (EMR) in order to calculate sedation frequency for 4 hours after each PT/OT session in which PARO was used.

    Time frame: 4 hours after each of the 4 individual session

  12. Microbial Contamination Screening of PARO Robot Seal

    The ATP Monitoring with SystemSURE Plus Process uses a process which monitors levels of ATP Bioluminescence. The investigators will implement established cleaning protocols on the robot seal and then measure ATP after the PT/OT session by swabbing PARO on the following areas: head, right flipper, left flipper, bottom \[by on/off switch\], top left back area, top right back area, stomach \[underneath\].This measure outcome is reporting the percentage of how many screenings and subsequent cleanings were completed on the seal. Since this was a requirement, 100% of the screenings and subsequent cleanings were complete.

    Time frame: Once, immediately after the participant completed all study therapy sessions

  13. Activity Performance Form- Time of Session

    The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for time of session.

    Time frame: Immediately after each of the 4 individual session

  14. Activity Performance Form- Range of Motion Exercises

    The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for range of motion.

    Time frame: Assessed at each of up to 4 therapy sessions; values represent the sum across all sessions attended for each participant.

  15. Physiologic Variables-Blood Pressure

    Blood Pressure (systolic \& diastolic)

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  16. Physiologic Variables-Respiratory Rate

    Respiratory Rate

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  17. Physiologic Variables- Oxygen Saturation

    Oxygen Saturation

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  18. Physiologic Variable- Heart Rate

    Heart Rate

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  19. Opinion on Pets

    18-item instrument with seven-point Likert scale (1-strongly disagree to 7-strongly agreed) designed to measure the favorableness of attitudes toward pets. Minimum Score = 18; Maximum score = 126. The higher the score, the more favorable a patient feels towards pets.

    Time frame: Prior to the start of the first therapy session.

  20. Parent/Guardian Stress- Total Difficultly

    42-item instrument with a five-point Likert scale designed to measure stress in parents whose child has a chronic illness or requires prolonged medical monitoring. It includes four domains or subscales. Minimum Score = 42; Maximum Score = 210. Higher scores indicate higher stress.

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  21. Parent/Guardian Anxiety

    Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the anxiety score.

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  22. Parent/Guardian Depression

    Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the depression score.

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  23. Mood/Affect

    The PANAS-10 is a 10-item instrument that asks the child to rate adjectives of varying mood states according to how often the child feels joyful, cheerful, happy, lively, proud, miserable, mad, afraid, scared, and sad. The item response uses a five-point Likert scale ranging from 1 ('very slightly or none at all') to 5 ('extremely'). The instrument yields two subscales: Positive Affect (joyful, cheerful, happy, lively, proud) and Negative Affect (miserable, mad, afraid, scared, sad), each summed from 5 items. Each subscale ranges from a minimum of 5 to a maximum of 25. Higher scores on the Positive Affect subscale indicate more positive affect (a better outcome). Higher scores on the Negative Affect subscale indicate more negative affect (a worse outcome).

    Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.

  24. Change in Motivation to Participate in Therapy

    The Pediatric Motivation Scale for Rehabilitation is a 19-item scale with a six-point smiley-face response format (1 = not true at all to 6 = definitely true) that measures motivation from a child's perspective, assessed after each therapy session. It has six subscales: Effort/Importance, Interest/Enjoyment, Competence, Relatedness, Autonomy, and Value/Usefulness. Negatively worded items are reverse-scored prior to analysis. Each subscale score is the average of its items, ranging from 1 to 6, with higher scores indicating a higher level of that concept (a more favorable outcome). Values reported represent the change in each subscale score from the participant's first therapy session to their last therapy session attended.

    Time frame: Change from the participant's first therapy session to their last therapy session attended (up to 4 sessions).

07

Results

Posted Oct 28, 2026

Participant flow

Participant flow — Overall Study
MilestonePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro RobotParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro Robot
Started12141213
Completed12141213
Not completed0000

Outcome measures

PrimaryPain: Wrong-Baker FACES Pain Rating Scale

The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · units on a scale
Pain: Wrong-Baker FACES Pain Rating Scale
units on a scalePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Pain: Wrong-Baker FACES Pain Rating Scale-0.17 ± 1.510.15 ± 2.38
PrimaryAnxiety: Children's Anxiety Meter-State (CAM-S)

The Children's Anxiety Meter-State (CAM-S) scale is a visual drawing used to measure anxiety in children. It is drawn to resemble a thermometer with a bulb at the bottom and horizontal lines at intervals going up to the top. The child is instructed to indicate with a line how they are feeling. The bottom of the thermometer minimum number is 0, which represents not worried or not nervous with anxiety increasing as it goes to the top of the thermometer with a max number of 10, representing very worried or very nervous.

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · units on a scale
Anxiety: Children's Anxiety Meter-State (CAM-S)
units on a scalePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Anxiety: Children's Anxiety Meter-State (CAM-S)0.21 ± 0.750.025 ± 2.46
PrimaryIntervention Acceptability

Patient Satisfaction Measure: Investigator-developed Satisfaction Measure contains one item which asks the participants to rank their satisfaction with the intervention from 1-5 (1 being not at all satisfied and 5 being very much satisfied)

Time frame:
Assessed within 1 week following the participant's final (up to 4th) therapy session
Reported as:
Mean · units on a scale
Intervention Acceptability
units on a scalePhysical and Occupational Therapy With Paro Robot
Intervention Acceptability5 ± 0
PrimaryNumber of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)

A count of Central Line Associated Blood Stream Infections (CLABSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)01
PrimaryNumber of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)

A count of Catheter-Associated Urinary Tract Infections (CAUTI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)00
PrimaryNumber of Hospital Acquired Infections-Enteroviruses

A count of Enteroviruses infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections-Enteroviruses
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections-Enteroviruses01
PrimaryNumber of Hospital Acquired Infections-Influenza

A count of Influenza infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections-Influenza
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections-Influenza00
PrimaryNumber of Hospital Acquired Infections-Multi-Drug Resistant Organisms

A count of Multi-Drug Resistant Organism infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections-Multi-Drug Resistant Organisms
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections-Multi-Drug Resistant Organisms00
PrimaryNumber of Hospital Acquired Infections-Surgical-Site Infections (SSI)

A count of Surgical-Site Infections (SSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections-Surgical-Site Infections (SSI)
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections-Surgical-Site Infections (SSI)00
PrimaryNumber of Hospital Acquired Infections Ventilator-Associated Pneumonia (VAP)

A count of Ventilator-Associated Pneumonia (VAP) infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.

Time frame:
Data collected starting from time of enrollment in the study until one week post last therapy session.
Reported as:
Number · Infections
Number of Hospital Acquired Infections Ventilator-Associated Pneumonia (VAP)
InfectionsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Number of Hospital Acquired Infections Ventilator-Associated Pneumonia (VAP)00
PrimaryTotal Number of Participants With Sedation Exposure

Sedative and analgesic medications will be abstracted from the electronic medical record (EMR) in order to calculate sedation frequency for 4 hours after each PT/OT session in which PARO was used.

Time frame:
4 hours after each of the 4 individual session
Reported as:
Count of participants · Participants
Total Number of Participants With Sedation Exposure
ParticipantsPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Total Number of Participants With Sedation Exposure21
PrimaryMicrobial Contamination Screening of PARO Robot Seal

The ATP Monitoring with SystemSURE Plus Process uses a process which monitors levels of ATP Bioluminescence. The investigators will implement established cleaning protocols on the robot seal and then measure ATP after the PT/OT session by swabbing PARO on the following areas: head, right flipper, left flipper, bottom \[by on/off switch\], top left back area, top right back area, stomach \[underneath\].This measure outcome is reporting the percentage of how many screenings and subsequent cleanings were completed on the seal. Since this was a requirement, 100% of the screenings and subsequent cleanings were complete.

Time frame:
Once, immediately after the participant completed all study therapy sessions
Reported as:
Number · percentage of screenings completed
Microbial Contamination Screening of PARO Robot Seal
percentage of screenings completedPhysical and Occupational Therapy With Paro Robot
Microbial Contamination Screening of PARO Robot Seal100
PrimaryActivity Performance Form- Time of Session

The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for time of session.

Time frame:
Immediately after each of the 4 individual session
Reported as:
Mean · minutes
Activity Performance Form- Time of Session
minutesPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Activity Performance Form- Time of Session30.03 ± 7.2332.83 ± 12.80
PrimaryActivity Performance Form- Range of Motion Exercises

The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for range of motion.

Time frame:
Assessed at each of up to 4 therapy sessions; values represent the sum across all sessions attended for each participant.
Reported as:
Number · Exercises
Activity Performance Form- Range of Motion Exercises
ExercisesPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Active Range of Motion8487
Active Assist Range of Motion1120
PrimaryPhysiologic Variables-Blood Pressure

Blood Pressure (systolic \& diastolic)

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · mmHg
Physiologic Variables-Blood Pressure
mmHgPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Systolic Change-2.55 ± 9.692.94 ± 13.58
Diastolic Change-0.96 ± 10.966.91 ± 11.98
PrimaryPhysiologic Variables-Respiratory Rate

Respiratory Rate

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · respirations per minute
Physiologic Variables-Respiratory Rate
respirations per minutePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Physiologic Variables-Respiratory Rate-0.7 ± 4.33-0.8 ± 4.49
PrimaryPhysiologic Variables- Oxygen Saturation

Oxygen Saturation

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · percentage of oxygen saturation
Physiologic Variables- Oxygen Saturation
percentage of oxygen saturationPhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Physiologic Variables- Oxygen Saturation-0.55 ± 3.15-0.43 ± 2.97
PrimaryPhysiologic Variable- Heart Rate

Heart Rate

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · beats per minute
Physiologic Variable- Heart Rate
beats per minutePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Physiologic Variable- Heart Rate2.23 ± 17.281.61 ± 12.19
PrimaryOpinion on Pets

18-item instrument with seven-point Likert scale (1-strongly disagree to 7-strongly agreed) designed to measure the favorableness of attitudes toward pets. Minimum Score = 18; Maximum score = 126. The higher the score, the more favorable a patient feels towards pets.

Time frame:
Prior to the start of the first therapy session.
Reported as:
Mean · units on a scale
Opinion on Pets
units on a scalePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Opinion on Pets110.56 ± 8.20105.46 ± 19.14
PrimaryParent/Guardian Stress- Total Difficultly

42-item instrument with a five-point Likert scale designed to measure stress in parents whose child has a chronic illness or requires prolonged medical monitoring. It includes four domains or subscales. Minimum Score = 42; Maximum Score = 210. Higher scores indicate higher stress.

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · units on a scale
Parent/Guardian Stress- Total Difficultly
units on a scaleParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro Robot
Parent/Guardian Stress- Total Difficultly-12.22 ± 19.06-1.71 ± 20.81
PrimaryParent/Guardian Anxiety

Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the anxiety score.

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · units on a scale
Parent/Guardian Anxiety
units on a scaleParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro Robot
Parent/Guardian Anxiety-1.9 ± 4.38-1 ± 3.97
PrimaryParent/Guardian Depression

Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the depression score.

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · units on a scale
Parent/Guardian Depression
units on a scaleParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro Robot
Parent/Guardian Depression-0.7 ± 2.21-0.27 ± 2.8
PrimaryMood/Affect

The PANAS-10 is a 10-item instrument that asks the child to rate adjectives of varying mood states according to how often the child feels joyful, cheerful, happy, lively, proud, miserable, mad, afraid, scared, and sad. The item response uses a five-point Likert scale ranging from 1 ('very slightly or none at all') to 5 ('extremely'). The instrument yields two subscales: Positive Affect (joyful, cheerful, happy, lively, proud) and Negative Affect (miserable, mad, afraid, scared, sad), each summed from 5 items. Each subscale ranges from a minimum of 5 to a maximum of 25. Higher scores on the Positive Affect subscale indicate more positive affect (a better outcome). Higher scores on the Negative Affect subscale indicate more negative affect (a worse outcome).

Time frame:
Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Reported as:
Mean · units on a scale
Mood/Affect
units on a scalePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Positive Affect1.93 ± 3.740.93 ± 4.36
Negative Affect-0.29 ± 2.7-0.91 ± 2.1
PrimaryChange in Motivation to Participate in Therapy

The Pediatric Motivation Scale for Rehabilitation is a 19-item scale with a six-point smiley-face response format (1 = not true at all to 6 = definitely true) that measures motivation from a child's perspective, assessed after each therapy session. It has six subscales: Effort/Importance, Interest/Enjoyment, Competence, Relatedness, Autonomy, and Value/Usefulness. Negatively worded items are reverse-scored prior to analysis. Each subscale score is the average of its items, ranging from 1 to 6, with higher scores indicating a higher level of that concept (a more favorable outcome). Values reported represent the change in each subscale score from the participant's first therapy session to their last therapy session attended.

Time frame:
Change from the participant's first therapy session to their last therapy session attended (up to 4 sessions).
Reported as:
Mean · units on a scale
Change in Motivation to Participate in Therapy
units on a scalePhysical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro Robot
Effort Importance Subscale-0.15 ± .880.15 ± 0.5
Interest Enjoyment Subscale0.33 ± 0.810.39 ± 1.05
Competence Subscale0.46 ± 1.050.5 ± 0.78
Relatedness Subscale0.15 ± 0.840.63 ± 1.45
Autonomy Subscale0.33 ± 0.76-0.35 ± 1.6
Value Usefulness Subscale-0.15 ± 0.850.41 ± 0.76

Adverse events

Collected over From enrollment until end of last therapy session, up to 4 session over 4 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Physical and Occupational Therapy With Paro Robot0/12 (0%)0/12 (0%)0/12 (0%)
Physical and Occupational Therapy Without Paro Robot0/14 (0%)0/14 (0%)0/14 (0%)
Parents/Guardians of Hospitalized Children Who Use Paro Robot0/12 (0%)0/12 (0%)0/12 (0%)
Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot0/13 (0%)0/13 (0%)0/13 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Physical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro RobotParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro RobotTotal
<=18 years12140026
Between 18 and 65 years00121325
>=65 years00000
Age, Continuous
Age, Continuous(years)Physical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro RobotParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro RobotTotal
Mean8.75 ± 3.7458.64 ± 2.79041.25 ± 6.56635.77 ± 6.23423.25 ± 15.89
Sex: Female, Male
Sex: Female, Male(Participants)Physical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro RobotParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro RobotTotal
Female98121342
Male36009
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Physical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro RobotParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro RobotTotal
American Indian or Alaska Native00000
Asian00000
Native Hawaiian or Other Pacific Islander00000
Black or African American11114
White1010111142
More than one race00000
Unknown or Not Reported13015
Region of Enrollment
Region of Enrollment(participants)Physical and Occupational Therapy With Paro RobotPhysical and Occupational Therapy Without Paro RobotParents/Guardians of Hospitalized Children Who Use Paro RobotParents/Guardians of Hospitalized Children Who do Not Use Paro RobotTotal
United States1214121351
08

Study locations

1 site
  • Children's Hosptial and Medical Center
    Omaha, Nebraska 68114, United States
09

References and documents

Publications

  • Fine AH. Handbook on Animal-Assisted Therapy: Theoretical Foundations and Guidelines for Practice. 4th ed. Burlington, MA: Academic Press; 2015
  • Bailey T, Christenson G, Lust K. The role of an animal-assisted interaction (AAI) program as a means of reducing stress and anxiety within a college community. Oxford, UK: Inter-Disciplinary Press.
  • Bailey T. Animal-assisted interactions (AAI): a creative modality to support youth with depression. In: Brooke SL, Myers CE, eds. The Use of the Creative Therapies in Treating Depression. Springfield, IL: Charles C. Thomas; 2015:269.
  • Burres S, Edwards NE, Beck AM, Richards E. Incorporating Pets into Acute Inpatient Rehabilitation: A Case Study. Rehabil Nurs. 2016 Nov;41(6):336-341. doi: 10.1002/rnj.260. Epub 2016 Mar 9. PubMed 26956570 ↗
  • Hetland B, Bailey T, Prince-Paul M. Animal Assisted Interactions to Alleviate Psychological Symptoms in Patients on Mechanical Ventilation. J Hosp Palliat Nurs. 2017 Dec;19(6):516-523. PubMed 29276432 ↗
  • Templer D.I., Arikawa H. (2011) The Pet Attitude Scale. In: Blazina C., Boyraz G., Shen-Miller D. (eds) The Psychology of the Human-Animal Bond. Springer, New York, NY. https://doi.org/10.1007/978-14419-9761-6_20
  • Streisand R, Braniecki S, Tercyak KP, Kazak AE. Childhood illness-related parenting stress: the pediatric inventory for parents. J Pediatr Psychol. 2001 Apr-May;26(3):155-62. doi: 10.1093/jpepsy/26.3.155. PubMed 11259517 ↗
  • Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003 Aug 1;1:29. doi: 10.1186/1477-7525-1-29. PubMed 12914662 ↗
  • Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988 Jan-Feb;14(1):9-17. No abstract available. PubMed 3344163 ↗
  • Ersig AL, Kleiber C, McCarthy AM, Hanrahan K. Validation of a clinically useful measure of children's state anxiety before medical procedures. J Spec Pediatr Nurs. 2013 Oct;18(4):311-9. doi: 10.1111/jspn.12042. Epub 2013 Jun 25. PubMed 24094126 ↗
  • Ebesutani C, Regan J, Smith A, Reise S, Higa-McMillan C, Chorpita BF. The 10-item positive and negative affect schedule for children, child and parent shortened versions: Application of item response theory for more efficient assessment. J of Psychopathol. Behav. Assess. 2012; 34(2), 191-203.
  • Tatla SK, Jarus T, Virji-Babul N, Holsti L. The development of the Pediatric Motivation Scale for rehabilitation. Can J Occup Ther. 2015 Apr;82(2):93-105. doi: 10.1177/0008417414556884. PubMed 26281433 ↗
  • Tracy MF, Chlan L, Savik K, Skaar DJ, Weinert C. A Novel Research Method for Determining Sedative Exposure in Critically Ill Patients. Nurs Res. 2019 Jan/Feb;68(1):73-79. doi: 10.1097/NNR.0000000000000322. PubMed 30540694 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2022 to primary completion in Jan 2025, 33 months.

Results were first posted in Oct 2026, 1 year 9 months after primary completion.

Of 207 non-industry interventional studies with no phase under Precursor Cell Lymphoblastic Leukemia-Lymphoma, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 66. This study's 33 months is close to that.

Counting every sponsor, half of 214 studies reached it within 32 months; a quarter within 12 and three quarters within 66.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2022
First posted
Mar 11, 2022
StartActual
Apr 1, 2022
Primary completionActual
Jan 3, 2025
CompletionActual
Jan 3, 2025
Results first posted
Oct 28, 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 28, 2026
Enrollment
25→51
Oct 28, 2026
Primary outcomes
17 edited, 3 time frame changed, 3 added, 3 description edited
What changed in the outcomes
  • EditedPain: Wrong-Baker FACES pain rating scalePain Rating ScaleTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • EditedNumber of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedNumber of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedNumber of Hospital Acquired Infections-EnterovirusesTime frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedNumber of Hospital Acquired Infections-InfluenzaTime frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedNumber of Hospital Acquired Infections-Multi-Drug Resistant OrganismsTime frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedNumber of Hospital Acquired Infections-Surgical-Site Infections (SSI)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedNumber of Hospital Acquired InfectionsVentilatorInfections Ventilator-Associated Pneumonia (VAP)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
  • EditedMicrobial Contamination Screening of PARO Robot SealTime frame: Completed immediately after each individual session → Once, immediately after the participant completed all study therapy sessions
  • EditedActivity performance formPerformance Form- Time of SessionTime frame: Immediately after each intervention therapy sesison → Immediately after each of the 4 individual session
  • EditedPhysiologic variablesVariables-Blood PressureTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • EditedPhysiologic variablesVariables-Respiratory RateTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • EditedPhysiologic variablesVariables- Oxygen SaturationTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • EditedParent/Guardian Stress- Total DifficultlyTime frame: Change from the start of the first therapy session to the end of the final therapy session. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • EditedParent/Guardian Anxiety and DepressionTime frame: Change from the start of the first therapy session to the end of the final therapy session. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • EditedChange in Motivation to Participate in TherapyTime frame: Immediately after each therapy session. → Change from the participant's first therapy session to their last therapy session attended (up to 4 sessions).
  • ChangedBefore Sedation ExposureNow Total Number of Participants With Sedation ExposureTime frame: 4 hours after each individual session → 4 hours after each of the 4 individual session
  • AddedActivity Performance Form- Range of Motion ExercisesTime frame: Assessed at each of up to 4 therapy sessions; values represent the sum across all sessions attended for each participant.
  • AddedPhysiologic Variable- Heart RateTime frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • AddedParent/Guardian DepressionTime frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • Time frameAnxiety: Children's Anxiety Meter-State (CAM-S)Change from before therapy session to immediately after therapy session is completed. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • Time frameIntervention AcceptabilityWithin 1 week of study completion → Assessed within 1 week following the participant's final (up to 4th) therapy session
  • Time frameMood/AffectChange from the start of the first therapy session to the end of the final therapy session. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
  • DescriptionAnxiety: Children's Anxiety Meter-State (CAM-S): how it is measured was reworded
  • DescriptionIntervention Acceptability: how it is measured was reworded
  • DescriptionMood/Affect: how it is measured was reworded
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Results posted
    Enrollment 25→51
    Primary outcomes 17 edited, 3 time frame changed, 3 added, 3 description edited
    What changed in the outcomes
    • EditedPain: Wrong-Baker FACES pain rating scalePain Rating ScaleTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • EditedNumber of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedNumber of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedNumber of Hospital Acquired Infections-EnterovirusesTime frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedNumber of Hospital Acquired Infections-InfluenzaTime frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedNumber of Hospital Acquired Infections-Multi-Drug Resistant OrganismsTime frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedNumber of Hospital Acquired Infections-Surgical-Site Infections (SSI)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedNumber of Hospital Acquired InfectionsVentilatorInfections Ventilator-Associated Pneumonia (VAP)Time frame: Chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. → Data collected starting from time of enrollment in the study until one week post last therapy session.
    • EditedMicrobial Contamination Screening of PARO Robot SealTime frame: Completed immediately after each individual session → Once, immediately after the participant completed all study therapy sessions
    • EditedActivity performance formPerformance Form- Time of SessionTime frame: Immediately after each intervention therapy sesison → Immediately after each of the 4 individual session
    • EditedPhysiologic variablesVariables-Blood PressureTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • EditedPhysiologic variablesVariables-Respiratory RateTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • EditedPhysiologic variablesVariables- Oxygen SaturationTime frame: Change from before therapy session to immediately after therapy session is completed → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • EditedParent/Guardian Stress- Total DifficultlyTime frame: Change from the start of the first therapy session to the end of the final therapy session. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • EditedParent/Guardian Anxiety and DepressionTime frame: Change from the start of the first therapy session to the end of the final therapy session. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • EditedChange in Motivation to Participate in TherapyTime frame: Immediately after each therapy session. → Change from the participant's first therapy session to their last therapy session attended (up to 4 sessions).
    • ChangedBefore Sedation ExposureNow Total Number of Participants With Sedation ExposureTime frame: 4 hours after each individual session → 4 hours after each of the 4 individual session
    • AddedActivity Performance Form- Range of Motion ExercisesTime frame: Assessed at each of up to 4 therapy sessions; values represent the sum across all sessions attended for each participant.
    • AddedPhysiologic Variable- Heart RateTime frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • AddedParent/Guardian DepressionTime frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • Time frameAnxiety: Children's Anxiety Meter-State (CAM-S)Change from before therapy session to immediately after therapy session is completed. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • Time frameIntervention AcceptabilityWithin 1 week of study completion → Assessed within 1 week following the participant's final (up to 4th) therapy session
    • Time frameMood/AffectChange from the start of the first therapy session to the end of the final therapy session. → Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
    • DescriptionAnxiety: Children's Anxiety Meter-State (CAM-S): how it is measured was reworded
    • DescriptionIntervention Acceptability: how it is measured was reworded
    • DescriptionMood/Affect: how it is measured was reworded
    + 1 other change: index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05275543
Responsible party
Sponsor
First posted
Mar 11, 2022
Start date
Apr 1, 2022
Primary completion
Jan 3, 2025
Completion
Jan 3, 2025
Results posted
Oct 28, 2026
Last update
Oct 28, 2026

Study contacts

Breanna D Hetland, PhD
principal investigator · University of Nebraska

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion